Natalizumab shows promise for teens with multiple sclerosis
(HealthDay)—Natalizumab may be safe in pediatric multiple sclerosis (MS) patients with highly active disease, according to a small study published online Feb. 18 in JAMA Neurology.
Feb 22, 2013
0
0